Moderna
MRNA
#1140
Rank
A$28.63 B
Marketcap
A$72.21
Share price
-1.52%
Change (1 day)
66.56%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -A$4.25 Billion

According to Moderna 's latest financial reports the company's current earnings are A$1.92 Billion. , an increase over its 2024 earnings that were of -A$5.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$3.99 Billion-23.03%
2024 -A$5.18 Billion-8.22%
2023 -A$5.64 Billion-140.65%
2022 A$13.86 B-27.81%
2021 A$19.20 B-1911.15%
2020 -A$1.07 Billion44.7%
2019 -A$0.74 Billion28.63%
2018 -A$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.42 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.60 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$32.36 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-A$68.46 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$60.28 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.83 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$0.49 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA